Alliqua BioMedical Inc, based in Eden Prairie, MN, is a biomedical products company that specializes in the development and manufacturing of electron-beam cross-linked hydrogels for the original equipment manufacturer market. Their hydrogel platform allows for the production of sheet gels with or without active ingredients, making it possible to effectively deliver prescription or over-the-counter medications, wound healing materials, and skincare ingredients. With a state-of-the-art manufacturing facility in Langhorne, PA, Alliqua provides custom hydrogels to meet the specific needs of their clients.
Alliqua BioMedical Inc has made significant strides in the biomedical industry, with recent news and developments including the spin-off and merger of their Contract Manufacturing Business with TO Pharmaceuticals LLC to create an independent, publicly traded company focused on cannabinoid-based pharmaceutical therapies. Additionally, they have announced a merger agreement with Adynxx, Inc. to create a NASDAQ-listed clinical-stage pharmaceutical company with a focus on pain and inflammation. Alliqua BioMedical Inc continues to innovate and contribute to the advancement of biomedical technologies.
Generated from the website